Profile data is unavailable for this security.
About the company
Boiron SA is a France-based pharmaceutical company engaged in the provision of homeopathic medicines. The Company develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. It also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, which works for the development of homeopathy within the world of medicine. Boiron SA operates through a number of subsidiaries, which are based in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others.
- Revenue in EUR (TTM)487.56m
- Net income in EUR11.34m
- Incorporated1967
- Employees2.77k
- LocationBoiron SA2 avenue de l ouest LyonnaisRONTALON 69510FranceFRA
- Phone+33 478456100
- Fax+33 478456291
- Websitehttps://www.boiron.fr/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ScinoPharm Taiwan Ltd | 94.23m | 7.20m | 394.67m | 1.01k | 54.95 | 1.26 | 18.14 | 4.19 | 0.3094 | 0.3094 | 4.05 | 13.51 | 0.2671 | 1.18 | 6.51 | -- | 2.04 | 2.55 | 2.18 | 2.71 | 36.61 | 40.54 | 7.64 | 9.59 | 5.09 | -- | 0.0612 | 104.55 | 6.91 | 3.32 | 18.22 | 9.39 | 22.27 | 5.33 |
| Boiron SA | 487.56m | 11.34m | 396.53m | 2.77k | 34.61 | 1.04 | 8.10 | 0.8133 | 0.6529 | 0.6529 | 28.08 | 21.78 | 0.8359 | 1.30 | 5.51 | 175,950.60 | 1.94 | 4.01 | 2.44 | 5.04 | 73.58 | 73.23 | 2.32 | 5.81 | 1.61 | -- | 0.0381 | 66.42 | -1.15 | -2.63 | -68.36 | -22.53 | -15.75 | 2.71 |
| Adcock Ingram Holdings Limited | 464.55m | 36.69m | 396.99m | 2.44k | 10.17 | 1.35 | -- | 0.8546 | 5.01 | 5.01 | 63.41 | 37.78 | 1.13 | 2.52 | 4.30 | 3,947,840.00 | 8.90 | 10.24 | 12.85 | 14.44 | 32.70 | 30.34 | 7.90 | 9.05 | 0.8498 | -- | 0.1488 | 41.41 | 5.60 | 6.38 | -9.39 | 3.37 | -9.93 | 6.58 |
| Henan Taloph Pharmaceutical Stock Co Ltd | 209.19m | 3.65m | 397.10m | 2.21k | 99.39 | 2.12 | -- | 1.90 | 0.0588 | 0.0588 | 3.19 | 2.75 | 0.4892 | 3.22 | 1.73 | 797,462.90 | 0.9865 | 0.3241 | 1.97 | 0.6105 | 24.75 | 26.22 | 2.02 | 0.6331 | 0.9224 | 1.43 | 0.4197 | 52.82 | -6.21 | 8.16 | 16.00 | 2.61 | -19.14 | -- |
| JCR Pharmaceuticals Co Ltd | 194.22m | -27.95m | 403.66m | 987.00 | -- | 1.37 | -- | 2.08 | -38.86 | -38.86 | 267.09 | 386.12 | 0.3194 | 0.5309 | 2.43 | 33,507,600.00 | -4.54 | 5.86 | -7.10 | 9.33 | 65.73 | 73.83 | -14.20 | 13.60 | 0.666 | -26.06 | 0.4466 | 45.13 | -22.86 | 5.94 | -186.42 | -- | 15.37 | 20.11 |
| Shanghai Shenqi Pharmactcl Inv Mgt CoLtd | 231.54m | 7.40m | 404.84m | 1.27k | 56.47 | 1.51 | -- | 1.75 | 0.1188 | 0.1188 | 3.72 | 4.44 | 0.6093 | 4.76 | 5.31 | 1,543,607.00 | 1.77 | -0.6947 | 2.23 | -0.8656 | 45.52 | 53.83 | 2.90 | -1.04 | 2.68 | 26.53 | 0.0818 | -- | -12.48 | 1.23 | 25.24 | -3.20 | -13.91 | -- |
| Zhejiang Cheng Yi Pharmaceutical Co Ltd | 86.81m | 19.67m | 405.64m | 738.00 | 20.62 | 2.75 | -- | 4.67 | 0.5072 | 0.5072 | 2.24 | 3.80 | 0.4013 | 2.01 | 17.68 | 992,793.70 | 9.07 | 12.01 | 11.17 | 14.75 | 66.13 | 69.79 | 22.60 | 22.84 | 1.01 | -- | 0.1998 | 36.44 | 2.54 | 4.24 | 0.8129 | 10.94 | -23.56 | 12.84 |
| SIGA Technologies Inc | 102.16m | 41.20m | 405.76m | 46.00 | 9.93 | 2.21 | 9.74 | 3.97 | 0.6736 | 0.6736 | 1.68 | 3.03 | 0.4909 | 0.4597 | 9.51 | 2,615,876.00 | 19.80 | 27.72 | 25.04 | 33.36 | 76.55 | 86.06 | 40.33 | 44.28 | 6.28 | -- | 0.00 | 37.70 | -0.8561 | 38.99 | -13.01 | -- | 7.85 | -- |
| Precigen Inc | 3.57m | -132.99m | 405.97m | 143.00 | -- | -- | -- | 113.83 | -0.5714 | -0.5714 | 0.0151 | 0.0524 | 0.0319 | -- | 5.18 | 29,377.62 | -118.84 | -38.49 | -148.57 | -47.33 | -2.17 | 49.53 | -3,728.87 | -334.29 | -- | -- | 0.00 | -- | -36.95 | -46.64 | -31.63 | -- | -25.69 | -- |
Data as of Jul 04 2025. Currency figures normalised to Boiron SA's reporting currency: Euro EUR
4.18%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Financi�re de l'�chiquier SAas of 31 Mar 2025 | 238.57k | 1.36% |
| HMG Finance SAas of 31 Mar 2025 | 100.05k | 0.57% |
| Dimensional Fund Advisors LPas of 05 Jun 2025 | 82.17k | 0.47% |
| DNCA Finance SAas of 31 Mar 2023 | 74.85k | 0.43% |
| HC Capital Advisors GmbHas of 31 Mar 2025 | 59.26k | 0.34% |
| Amplegest SASas of 31 Dec 2024 | 46.82k | 0.27% |
| Amiral Gestion SAas of 31 Dec 2024 | 42.16k | 0.24% |
| Sycomore Asset Management SAas of 30 May 2025 | 38.68k | 0.22% |
| Norges Bank Investment Managementas of 31 Dec 2024 | 28.80k | 0.16% |
| Twenty First Capital SASas of 30 Jun 2023 | 21.50k | 0.12% |
More ▼
Data from 30 Jun 2024 - 03 Jul 2025Source: FactSet Research Systems Inc.
